Further analysis of the clinical outcome data showed that higher expression levels of these DDR genes in high-grade and/or low-grade gliomas are significantly associated with decreased survival (Fig. 6C and Supplementary Fig. S6). The gene discussed is DDR1; the disease is central nervous system cancer.